Prime IV’s $100M Year: Inside the Booming IV Therapy Gold Rush

COLORADO SPRINGS, CO – February 09, 2026 – Prime IV Hydration & Wellness, a company at the forefront of the rapidly expanding wellness industry, has capped off 2025 with staggering growth, officially crossing the $100 million threshold in systemwide revenue. The nation's largest IV therapy franchise has cemented its market dominance through aggressive expansion, service innovation, and a franchise model that is proving highly lucrative.

The Colorado-based company announced a 41% year-over-year revenue increase, a figure driven by the opening of 53 new locations in 2025. This expansion pushed its total footprint to 208 operating clinics nationwide, with a pipeline of 324 franchises sold across 42 states. The growth reflects a powerful consumer shift towards proactive and preventative health measures, a trend Prime IV has successfully capitalized on since its founding in 2017.

"2025 was a pivotal year for Prime IV," said Amy Neary, Founder and CEO of Prime IV Hydration & Wellness, in a statement. "From expanding our national presence to introducing new, science-backed wellness offerings and strengthening our support for franchise owners, every milestone we reached this year reflects the strength of our brand and the dedication of our franchisees."

A Record Year of Expansion and Accolades

The financial and expansion metrics paint a picture of a brand in high demand. Beyond the nine-figure revenue milestone, the company’s unit-level economics demonstrate significant profitability. Eight individual Prime IV locations surpassed $1 million in annual revenue, with the top-performing clinic generating an impressive $3.2 million—among the highest single-unit revenues in the category. This performance is bolstered by a 2.5% increase in brand-wide membership conversion, indicating a strong base of recurring customers seeking regular treatments.

The franchise world has taken notice. In 2025 and early 2026, Prime IV accumulated a trove of industry awards that underscore its market leadership. Entrepreneur Magazine ranked the company #1 in the IV Therapy Category for the third consecutive year and saw it jump 100 positions on its prestigious Franchise 500 list. Similarly, Inc. Magazine placed Prime IV at #597 on its 2025 Inc. 5000 list of fastest-growing private companies, a leap of 278 positions from the prior year.

Accolades from Franchise Business Review, which bases its rankings on direct franchisee feedback, further suggest a healthy internal ecosystem. The company was named a top franchise for women, veterans, and company culture, signaling that its rapid growth is built on a supportive foundation.

Neary credited the franchise owners for this success. "They are the face of Prime IV in their communities, and they bring our mission to life every single day," she stated. "These awards are a celebration of their passion, dedication and trust in this brand."

Beyond Hydration: Tapping into Proactive Health

Prime IV's success is not merely a story of expansion; it’s also one of evolution. The company is a key player in a market that has moved far beyond simple saline drips for hangovers. The global intravenous hydration therapy market was valued at nearly $3 billion in 2025 and is projected to more than double within the next decade, driven by a consumer base increasingly focused on longevity, anti-aging, and personalized health.

In 2025, Prime IV leaned heavily into this trend by expanding its menu of advanced wellness services. Key rollouts included Bioidentical Hormone Replacement Therapy (BHRT), Niagen (a precursor to NAD+), and Buccal nutrient strips. These offerings cater to a clientele seeking to optimize health at a cellular level.

NAD+ (Nicotinamide Adenine Dinucleotide) treatments, in particular, represent a burgeoning frontier. As a crucial coenzyme for cellular energy and DNA repair, NAD+ levels naturally decline with age. IV therapy that replenishes NAD+ is marketed with benefits ranging from enhanced cognitive function and mood to increased energy and cellular detoxification. While research is ongoing, the demand is undeniable, with the NAD+ protocol segment projected to grow at over 15% annually through 2030.

BHRT, which uses hormones molecularly identical to those produced by the body, is another popular offering aimed at mitigating the effects of aging. While proponents claim it is a safer alternative to conventional hormone therapy, medical bodies like the Mayo Clinic note that evidence for custom-compounded BHRT is limited, urging caution. Nonetheless, its inclusion on menus like Prime IV’s shows a clear response to consumer demand for anti-aging solutions.

Navigating the Wellness Wild West

The explosive growth of Prime IV and its competitors is unfolding within a complex and fragmented regulatory environment. Unlike many medical fields, IV therapy clinics are not governed by a single federal body. Instead, they operate under a patchwork of state-level rules, creating a veritable "Wild West" of compliance challenges.

This regulatory landscape dictates everything from who can own a clinic to who can administer a drip. In states with strict Corporate Practice of Medicine (CPOM) laws, such as California and Texas, a licensed physician must hold majority ownership of the medical entity. In contrast, states like Florida and Ohio offer more flexibility, allowing non-physician franchisees to own the business as long as a licensed medical director oversees all clinical operations and protocols.

This legal maze presents both a barrier to entry and a competitive advantage for sophisticated operators. A franchise system like Prime IV must develop a flexible yet compliant model that can be adapted to dozens of different regulatory environments. The company's commitment to a "disciplined growth framework" and investment in medical training and clinical oversight are critical components for navigating this territory safely and legally.

As the industry continues its rapid ascent, the tension between consumer demand for accessible wellness and the need for stringent medical safety standards will likely intensify. With plans to open more locations, introduce new services, and enhance franchisee support in 2026, Prime IV is not just riding the wave of a booming market—it is actively shaping its future.